Skip Navigation
Skip to contents

MDS

ICKMDS 2019

GNB 메뉴 보기

ICKMDS 2019 International Conference of Korean Movemet Disorder Society
October 18 Fri. ~ 20 Sun. 2019 Bexco Busan, Korea
Scientific Program

Poster List

Poster List

HOME > Scientific Program > Poster List
Poster# Title Presenter Country
P-1. Parkinson’s Disease
(01-09) Epidemiology/Genetics/Clinical Trials
P-1-01 Cancer Risk in Patients with Parkinson’s Disease in South Korea: A Nationwide, Population-based Cohort Study Do Young KWON Korea
P-1-02 Glutamate Ionotropic Receptor NMDA Type Subunit 2A (GRIN2A) Gene Polymorphism (rs4998386) and Susceptibility of Parkinson’s Disease: A Meta-analysis Gaurav NEPAL Nepal
P-1-03 Association of ZNF184, IL1R2, LRRK2, ITPKB and PARK16 with Sporadic Parkinson's Disease in Eastern China Ran ZHENG China
P-1-04 A Meta-analysis of Differentially Expressed Genes of Dopamine Neuron in Substantia Nigra in Parkinson's Disease Phung My DUONG Vietnam
P-1-05 Genomic Analysis Identifies New LOCI Associated With Wearing off in Parkinson's Disease Ho-Sung RYU Korea
P-1-06 The Variants of Autophagy Genes of Early-onset Parkinson’s Disease in South Korea Eungseok OH Korea
P-1-07 Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson Disease Ji-Hyun CHOI Korea
P-1-08 Neuroprotective Effects of Rasagiline in Parkinson’s Disease: A Regional Cerebral Blood Flow Study Yong-An CHUNG Korea
P-1-09 A Multicenter Double-blind, Randomized,Placebo-controlled Trial of DA-9701 in Parkinson’s Disease Patients with Gastrointestinal Dysfunction Jee-Young LEE Korea
P-1. Parkinson’s Disease
(10-39) Imaging/Electrophysiology
P-1-10 Striatal Asymmetry Index and Its Correlation with the Hoehn & Yahr Stage in Parkinson's Disease Wei LIN China
P-1-11 Clinical Features and Cerebral Metabolic Abnormalities in Parkinson's Disease with Atrophy in the Nucleus Basalis of Meynert Miyeong GANG Japan
P-1-12 “Depressed” Caudate and Ventral Striatum Dopamine Transporter Availability in Depressed Parkinson’s Disease Sang-Won YOO Korea
P-1-13 Neuropsychiatric Symptoms and Striatal Dopamine Activity in Early Parkinson’s Disease without Dementia Yoon-Sang OH Korea
P-1-14 The Patterns of Olfactory Functional Networks Between Parkinson’s Disease Dementia and Alzheimer’s Dementia  Yang Hyun LEE Korea
P-1-15 Low Thalamic Monoamine Transporter Availability is Related to Excessive Daytime Sleepiness in Early Parkinson’s Disease Yoonha HWANG Korea
P-1-16 Intervening Effects of Orthostatic Blood Pressure Change on Subcortical Atrophy and Cognition in Early Parkinson’s Disease Sang-Won YOO Korea
P-1-17 Clinical and striatal Dopamine Transporter Correlates of Mild Behavioral Impairment in Parkinson’s Disease Han Soo YOO Korea
P-1-18 White Matter Hyperintensities as a Predictor of Freezing of Gait in Parkinson’s Disease Seok Jong CHUNG Korea
P-1-19 Quantitative Autonomic Testing and Myocardial MIBG Scintigraphy in Parkinson’s Disease Yoon kyung LEE Korea
P-1-20 Non-motor Burden is Associated with the Patterns of Striatal Dopamine Loss in De Novo Parkinson’s Disease Seok Jong CHUNG Korea
P-1-21 Visualization of Neuromelanin in the Postmortem Substantia Nigra with Combined T2 and T2* Relaxometry Jae-Hyeok LEE Korea
P-1-22 Individual Level Prediction of Progressive Mild Cognitive Impairment in Parkinson’s Disease Using Machine Learning Based-algorithm Na-Young SHIN Korea
P-1-23 Waiting and Waiting on Dopamine Transporter Imaging in Drug Induced Parkinsonism Ji Young YUN Korea
P-1-24 Clinical Significance of MRI in the Diagnosis of Parkinson’s Disease Jung Won CHOI Korea
P-1-25 Alterations of Thalamic Nuclei Volumes and Intrinsic Network in Parkinson Disease according to Predominant Symptoms Dong Ah LEE Korea
P-1-26 Iron Deposition in Deep Brain Structures is Related with Non-motor Symptoms in Early Parkinson’s Disease Minkyeong KIM Korea
P-1-27 18F-FP-CIT PET Has a Predictive Value for Motor Outcome in Drug Naïve PD Patients Minkyeong KIM Korea
P-1-28 Tracts Based Analysis of White Matter Integrity in Parkinson Disease Seung-Hwan LEE Korea
P-1-29 Evaluation of the Usefulness of SMwI Nigrosome 1 MRI for Differentiating Subclinical Parkinson’s Disease in Idiopathic REM Sleep Behavior Disorder Young Hee SUNG Korea
P-1-30 Association between Retinal Changes and Clinical Manifestations in de novo Parkinson's Disease Soo Hyun CHO Korea
P-1-31 Neural Substrates of Motor Reserve in Early Parkinson’s Disease Hang-Rai KIM Korea
P-1-32 Axial Symptoms are Characteristic Symptoms in Drug-Naïve Parkinson’s Disease. Patients with Severe White Matter Lesions Assessed by Fazekas Scores Tae Hwan SEOK Korea
P-1-33 Fecal Short Chain Fatty Acids Correlate to the Motor Severity in Parkinson's Disease Szu-Ju CHEN Taiwan
P-1-34 Altered Gut Microbiota and Inflammatory Cytokine Responses in Patients with Parkinson Disease Wan-Ling CHANG Taiwan
P-1-35 Computational Interaction Studies of Selective Biomarkers of Parkinson Disease with Potential Peptides from Beans Plants Chakresh JAIN India
P-1-36 Parkinson's Disease Diagnosis and Progression Monitoring by Mass Spectrometry SRM Assay Catherine PAN United States
P-1-37 Quantitative EEG and Migraine in Patients with Parkinson’s Disease Seung Hyun LEE Korea
P-1-38 Project Study: The Relationship between Motor, Non-motor Symptoms and Biomarkers of Parkinson's Disease Puntsagdulam BYAMBAJAV Mongolia
P-1-39 Preserved Serotonergic Activity in Early-onset Parkinson’s Disease using Loudness Dependence of Auditory Evoked Potentials Hee Kyung PARK Korea
P-1. Parkinson’s Disease
(40-73) Biomarker/Phenomenology
P-1-40 Olfactory Anosognosia is A Predictor of Cognitive Decline and Dementia Conversion in Parkinson’s Disease Han Soo YOO Korea
P-1-41 Sex-specific Association of Rrate and Levodopa-induced Dyskinesia in Parkinson’s Disease Jin Ho JUNG Korea
P-1-42 Neuropathological Findings of Two Patients with Parkinson’s Disease Seok Hwi JEON Korea
P-1-43 Wearable Accelerometer for Freezing of Gait Showed Different Accuracy in Various Conditions in Parkinson’s Disease Eunyoung HAN Korea
P-1-44 Reliable Indicators of Autonomic Function Test in Parkinson’s Disease Byeol-A YOON Korea
P-1-45 Association of Plasma α-synuclein with Cardiac Sympathetic Denervation and White Matter Hyperintensities in Early Parkinson's Disease Dong Gyu PARK Korea
P-1-46 Effects of COM Cariables on Maximum Speed 360°&540° Turning Task by Disease-dominant Side and with and without Freezing of Gait in Parkinson’s Disease Patients Hwayoung PARK Korea
P-1-47 An Association between Pregnancy and Onset of Parkinson's Disease Ilsoo KIM Korea
P-1-48 Interocular Retinal Thickness and Asymmetric Motor Symptoms in Parkinson’s Disease   Yoo Ha HONG Korea
P-1-49 Assessment of Balance and Functional Status in Patients with Parkinson’s Disease: Reliability and Validity of the Russian Version of the Berg Balance Scale Aleksey ZIMIN Russian Federation
P-1-50 Sex-dependent Association of Urate on the Patterns of Striatal Dopamine Depletion in Parkinson’s Disease Kyoungwon BAIK Korea
P-1-51 A New Method for Quantitative Evaluation of Motor Symptoms of Patients with Parkinson's Disease Jongho LEE Japan
P-1-52 Some Associations of Cognitive Impairment in Mongolian Patients with Parkinson’s Disease Bolortsetseg KHATANBAATAR Mongolia
P-1-53 Fall Risk among Patients with Parkinson's Disease Tungalag ENKHBAT Mongolia
P-1-54 Literature Review on Intervention of Parkinson’s Disease in Korea Ok Hee KIM Korea
P-1-55 Gait and Cognition in Parkinson’s Disease Byung Cheol GWAK Korea
P-1-56 The Association between Fatigue and Autonomic Dysfunction in the Patients with Drug Naïve Parkinson’s Disease Jong Hyeon AHN Korea
P-1-57 Trunk-pelvis Coordination during Gait in Early de-novo Parkinson’s Disease Jinhee KIM Korea
P-1-58 Post-cessation Weight Gain and Risk of Parkinson’s Disease in Men: Analysis from National Cohort Data Ryul KIM Korea
P-1-59 REM Sleep Behavior Disorders in de novo Parkinson’s Disease is a Marker for Poor Prognosis of Disease Progression Young Eun KIM Korea
P-1-60 A Validation Study for the Subjective Cognitive Decline Questionnaire for Parkinson’s Disease (SCDQ-PD) Jin Yong HONG Korea
P-1-61 Withdrawn    
P-1-62 Impacts of Freezing of Gait on 360° Turning in Parkinson’s Disease Minji SON Korea
P-1-63 A Study for Bone Mineral Density of Patients with Parkinson's Disease JongSik PARK Korea
P-1-64 Difference of Neuropsychological Characteristics between Parkinson’s Disease associated with Mild Dementia and Parkinson’s Disease without Dementia MinCheol SHIN Korea
P-1-65 REM Sleep Behavior Disorder in Parkinson’s Disease Patients with and without Freezing of Gait: Polysomnographic Evaluation Hyun Joon LEE Korea
P-1-66 Musculoskeletal Problems in Parkinson’s Disease Patients Have No Association with Socioeconomic Status Ahro KIM Korea
P-1-67 Vocal Analysis in Parkinson’s Disease and Essential Tremor: A Machine-Learning Approach Jung E PARK Korea
P-1-68 The Validation Study of Korean Version Swallowing Disturbance Questionnaire in Parkinson’s Disease Wooyoung JANG Korea
P-1-69 Comparison of the Korean Form of Mini-Mental State Examination and the Korean Form of Montreal Cognitive Assessment in Patients with Parkinson’s Disease Jiah KIM Korea
P-1-70 Difference of the Oculomotor Abnormalities between Idiopathic Parkinson’s Disease and Other Parkinsonian Disorders   Seok-Jun KIM Korea
P-1-71 Usefulness of Visuospatial Function Tests according to the Severity of Cognitive Impairments in Patients with Parkinson’s Disease Minji SONG Korea
P-1-72 Decreased Baroreflex Sensitivity Correlates with Orthostatic Hypotension, Supine Hypertension and Cardiovascular Dysautonomia in Parkinson’s Disease Heejeong JEONG Korea
P-1-73 Cognitive Profiles of Idiopathic Parkinson’s Disease and Secondary Parkinsonism in Patients with Mild Cognitive Impairment Jihyang KIM Korea
P-1. Parkinson’s Disease
(74-96) Treatment
P-1-74 Uric Acid Enhances Neurogenesis in Parkinsonian Model Ji-Eun LEE Korea
P-1-75 Efficacy of Nicergoline Treatment in Parkinson’s Disease Associated with Dementia In-Uk SONG Korea
P-1-76 Effects of Levodopa on Gait Asymmetry in Advanced Parkinson’s Disease Jong Hyeon AHN Korea
P-1-77 Tango Therapy for Parkinson’s Disease: Effects of Rush Elemental Tango Therapy (RETT) Youngsoon KOH Korea
P-1-78 Transcranial Direct Current Stimulation for Limb-Kinetic Apraxia in Parkinson's Disease Jung E PARK Korea
P-1-79 Anodal Transcranial Direct Current Stimulation Could Modulate Cortical Excitability Reflecting Central Cholinergic Dysfunction Wooyoung JANG Korea
P-1-80 Anodal Transcranial Direct Current Stimulation Could Alleviate Dysphagia in Parkinson’s Disease Patients Wooyoung JANG Korea
P-1-81 The Effect of Baseline Cognitive Status of Parkinson’s Disease on the Outcome after Deep Brain Stimulation Surgery Kye Won PARK Korea
P-1-82 The Effectiveness of Balance Exercises by Means of Virtual Reality Games in Parkinson's Disease Geun-Ho LEE Korea
P-1-83 Study of Protective Effects of 17-beta-estradiol: Relevance to Depressive Symptoms in Parkinson’s Disease Pardeep KUMAR India
P-1-84 Neuro-modulatory Activity of Naringenin in Rotenone-induced Neurotoxicity in Mice Model of Parkinson’s Disease via Suppressing NF-κB Pathway Vikas KUMAR India
P-1-85 Pathological Alpha Synuclein Propagation and Microglial Inflammatory Response in Alpha Synuclein Pre-Formed Fibrils Injected Mouse Model Thuy Thi LAI Vietnam
P-1-86 Parkin Gene Associated with the Suppression of TAF15-induced Neuronal Defects in Drosophila Eu Jene CHOI Korea
P-1-87 Generation of expandable Human Induced Dopaminergic Neuronal Progenitors for Parkinson’s Disease Therapy Minhyung LEE Korea
P-1-88 Transcriptome Modification of Anodal Transcranial Direct Current Stimulation in Transgenic Parkinson’s Disease Mouse Model Wooyoung JANG Korea
P-1-89 Spatial Distribution of Functional Clusters Coding for Reward and Movement Information in the Striatal Direct and Indirect Pathways Junghwan SHIN Korea
P-1-90 Withdrawn    
P-1-91 Novel Compound Berberine Mitigates the Rotenone Induced Neutrotoxicity in IMR-32 Neuroblastoma Cells of Parkinson’s Disease (PD) Deepika SINGH India
P-1-92 Intranasally Delivered Mesenchymal Stem Cells Can Protect a Nigrostriatal Loss in Prodromal Parkinson’s Disease Mice Model YoungEun HUH Korea
P-1-93 Sarcopenia in Patients with Parkinson’s Disease; Web-based Multicenter Prospective Cohort Study, Sarcopenia Study Group (SSG) Eungseok OH Korea
P-1-94 Hyposmia predicts the Development of Axial Motor Manifestations in Parkinson's Disease Jae-jung LEE Korea
P-1-95 Neuropsychiatric Symptoms, Cognitive Profile and Activities of Daily Living in Patients with Parkinson's Disease and Dementia with Lewy Bodies Hyun Sook KIM Korea
P-1-96 Dysphagia and Myocardial 123I-metaiodobenzylguanidine Uptake in Parkinson’s Disease Yoon-Sang OH Korea
P-2. Other Movement Disorders
(01-09) Epidemiology/Imaging
P-2-01 Old-onset Multiple System Atrophy: A Korean Multicenter Cohort Study Yang Hyun LEE Korea
P-2-02 Dopaminergic Depletion, β-amyloid Burden, and Cognition in Lewy Body Disease Han Soo YOO Korea
P-2-03 Association of Putaminal Rating Scale with Quantitative MRI Parameters and Genetic Variants Myung Jun LEE Korea
P-2-04 The Nigral Hyperintensity on 3 Tesla Susceptibility-weighted MRI in Patients with Vascular Parkinsonism Kyeong Joon KIM Korea
P-2-05 Microbleeds in the Basal Ganglia Associated with Freezing of Gait Dong-Ha KIM Korea
P-2-06 A Conundrum of Normal Pressure Hydrocephalus and Progressive Supranuclear Palsy Jae Young JOO Korea
P-2-07 Can Basal Ganglia Lesions Explain Motor Severity in Vascular Parkinsonism with Normal Dopamine Transporter Imaging? Dong Gyu PARK Korea
P-2-08 Cerebrospinal Fluid Makers of Idiopathic Normal Pressure Hydrocephalus Associated with Blood Brain Barrier Dysfunction Eungseok OH Korea
P-2-09 An Autopsy Confirmed Case with Diffuse Cortical Predominant Lewy Body Pathology Eun Joo CHUNG Korea
P-2. Other Movement Disorders
(10-30) Genetics/Phenomenology
P-2-10 Frequency of Red Flags and Other Associated Symptoms in Multiple System Atrophy Yu Jin JUNG Korea
P-2-11 Quantitative Gait Analysis and Cerebrospinal Fluid Tap Test for Idiopathic Normal-pressure Hydrocephalus Kyunghun KANG Korea
P-2-12 Early Impairment of Chopstick Skills in Parkinsonism Suggests Progressive Supranuclear Palsy Young Eun KIM Korea
P-2-13 An Objective Data-driven Approach to the Study of Clinical Heterogeneity in Multiple System Atrophy (MSA): The Identification of the Three Distinct Clnical MSA Subgroups Hui-Jun YANG Korea
P-2-14 Gait and Ataxia Severity in Patients with Cerebellar Ataxia Pan-Woo KO Korea
P-2-15 TOR1A, RAB12, and KMT2B Found in Patients with Undiagnosed Dystonia Involving Cervical Region Aryun KIM Korea
P-2-16 Enhanced Brain Activity for Motor Preparation Related to Sensory Tricks in Cervical Dystonia Hae-Won SHIN Korea
P-2-17 Neuropsychiatric Non-motor Manifestations in Patients with Focal Dystonia Sangjin LEE Korea
P-2-18 Synaptic Pathology of Cerebellar Climbing Fibers as a Pathogenesis of Essential Tremor Yi-Mei WANG Taiwan
P-2-19 Genotype-Phenotype Correlation of PLA2G6-Associated Neurodegeneration in Adults: Case Series and Review of Literature Yung-Tsai CHU Taiwan
P-2-20 Abnormal Brain Metabolic Network and Clinical Progression in REM Sleep Behavior Disorder Dallah YOO Korea
P-2-21 Difference of Frequency and Power between Dementia Patients with and without Rapid Eye Movement (REM) Sleep Problems YongSoo SHIM Korea
P-2-22 Improvisation of Classification Performance Based on Feature Optimization for Differentiation of Parkinson’s Disease from Other Neurological Diseases Using Gait Characteristics Jinse PARK Korea
P-2-23 Spectrum of Dystonia in Encephalitis: A Hospital-based Cohort Study Usha Kant MISRA India
P-2-24 Dystonia in Neurological Wilson Disease Jayantee KALITA India
P-2-25 Spectrum of Glutamic Acid Decarboxylase Antibody Related Disorder in a Single Center in Taiwan Yih-Chih KUO Taiwan
P-2-26 The Difference of Timed up and Go Test in Elderly: Geriactric Nursing Home vs. Community Amiroh DEWI Indonesia
P-2-27 Clinical Characteristics of Patients with Idiopathic REM Sleep Behavior Disorder (RBD): Comparing Groups with Short-term, Intermediate-term, and Long-term Disease Duration in Remainders  Sooyeoun YOU Korea
P-2-28 Dose Hypomagnesiumemia Have Relevance to Eyelid Myokymia? MunKyung SUNWOO Korea
P-2-29 Movement Disorders Associated with Intracranial and Extracranial Artery Diseases Nari CHOI Korea
P-2-30 Development of a Web-based Tool for Systematic Collection of Phenotypes of Hereditary Movement Disorders from Medical Literature Sangkyoon HONG Korea
P-2. Other Movement Disorders
(31-40) Treatment
P-2-31 Long Term Zinc Therapy Improves Movement Disorders in Neurological Wilson Disease Vijay KUMAR India
P-2-32 Memantine Inhibits Transmission of α-synuclein by Modulating Clathrin-mediated Endocytosis in a Parkinsonian Model Ha Na KIM Korea
P-2-33 Bisphenol A Exposure Aggravate Neurological Dysfunctions via Toxicity and Inflammation Dhananjay YADAV India
P-2-34 Neuroprotective Potential of Ethanolic Extract of Aspargus Racemosus Against Haloperidol Induced Neurotoxicity in the Experimental Model of Parkinson’s Disease Deepika SINGH India
P-2-35 Butanolic Fraction of Withania Somnifera Mitigates Scopolamine-induced Cognitive Impairment and Motor Deficit in the Experimental Model of Alzheimer’s Disease in Animals Manvendra SINGH India
P-2-36 Neuroprotective and Anti-radical Potential of Butanolic Extract of Myristica Fragrans against Scopolamine-Induced Cognitive Deficit in the Experimental Model of Alzheimer’s Disease  Manvendra SINGH India
P-2-37 Neonatal Bacterial (LPS) Infection Induces the Permanent Impairments in Motor dDeficits: Focus on Link between Infection Induced Neuroinflammation, Glia Cells and Demyelination Kavita SOLANKI India
P-2-38 Molecular Docking Studies and Cognitive Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer’s Disease Like Condition Pankajkumar YADAV India
P-2-39 Possible Neuroprotective Effect of Cholorogenic Acid and Protocatechuic Acid Combinational Approach against Scopolamine-induced Cognitive Impairment in a Mouse Model as a Multitargeted Ligand Ekta YADAV India
P-2-40 Effect of Herbal Medicine against Parkinson’s Diseases - An in Silico Approach Senthil Kumar SUBRAMANI India
P-3. Case Reports
(01-22) Hypokinetic Movement Disorders
P-3-01 Intrafamilial Variability and Clinical Heterogeneity in a Family with PLA2G6-Associated Neurodegeneration Jongkyu PARK Korea
P-3-02 Visual Hallucination in Posterior Cortical Atrophy: Lewy Body Disease Variant of Alzheimer’s Disease or Dementia with Lewy Bodies? Sang-Won YOO Korea
P-3-03 Diagnostic Value of Evan’s Index Revisited: A Case of Idiopathic Normal Pressure Hydrocephalus with Evans’ index Less Than 0.3 Hyunjin JU Korea
P-3-04 A Case of Hyperglycemic Encephalopathy with Magnetic Resonance Images Mimicking Sporadic Creutzfeldt-Jakob Disease In Hee KWAK Korea
P-3-05 An Elderly Woman Presenting with Progressive Cerebellar Ataxia with ‘Wine Glass’ Sign Hongchul AHN Korea
P-3-06 ‘Pseudo-mesencephalic Ptosis’ in an Early Parkinson’s Disease Patient Sang-Won YOO Korea
P-3-07 An Unusual Presentation of Hypertrophic Ovary Degeneration without Palatal Tremor Kyum-Yil KWON Korea
P-3-08 Shunt-responsive Choreodystonia and Dementia in Patient Revealed Normal Pressure Hydrocephalus Kayeong IM Korea
P-3-09 Thyrotoxicosis Causing Drug-induced Parkinsonism in a Patient with Long-term Haloperidol Treatment Su Jin CHUNG Korea
P-3-10 Hypoparathyroidism First Presenting with Pathologic Laughing and Parkinsonism: A Case Report Jeeun LEE Korea
P-3-11 Clinical Evolution of Multiple System Atrophy (MSA) in a Patient with Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Description from a Prospective Follow-up Junghwan SHIN Korea
P-3-12 A Patient with Parkinson’s Disease Presented with Atypical Isolated Position-specific Proximal Leg Tremor Sangmin PARK Korea
P-3-13 Adult-onset Levodopa Responsive Parkinsonism in Huntington’s Disease Sungsik AN Korea
P-3-14 Unilateral Leg Tremor on Sitting Crossed-legged Position as the Initial Manifestation of Parkinson's Disease Won Tae YOON Korea
P-3-15 Primary Lateral Sclerosis Mimicking Atypical Parkinsonism Hye Jeong OH Korea
P-3-16 2 Cases with Improved Quality of Life by Intravenous Glutathione in Advanced Parkinson's Disease Sun-Ah CHOI Korea
P-3-17 Reversible Parkinsonism Caused by Influenza B-associated Encephalitis Affecting Bilateral Basal ganglia: A case Report Yueli ZHU China
P-3-18 A Case of Autosomal Dominant Spinocerebellar Ataxia Patient in District Hospital   Bolortsetseg DAVAASUREN Mongolia
P-3-19 Acute Cerebellar Ataxia following Influenza Vaccination Nomindalai BATBOLD Mongolia
P-3-20 A Case of Young onset Parkinson’s Disease Enkhjargal MANJIILAA Mongolia
P-3-21 Case Report: Tick-borne Encephalitis and Parkinsonism Enkhjargal MANJIILAA Mongolia
P-3-22 Clinical Features of Vascular Parkinsonism and Comparison with Parkinson’s Disease Odgerel OCHIRKHUU Mongolia
P-3. Case Reports
(23-42) Hyperkinetic Movement Disorders
P-3-23 Unilateral Pseudo-orthostatic Tremor in a Parkinson’s Disease Patient Jean Hee KIM Korea
P-3-24 Task Specific Dystonic Tremor of Lower Extremity: Vehicle Brake Specificity MyungAh LEE Korea
P-3-25 Asymmetric Periodic Leg Movements during Sleep after Unilateral Supratentorial Infarction: Two Legs with One Lesion Sang-Won YOO Korea
P-3-26 Focal Lower Limb Dystonia only When Walking Down Stairs Misdiagnosed with Psychogenic Origin Jieun HAN Korea
P-3-27 Abnormal Movement (Hhemichorea-hemiballism and Dystonic feature) Accompanied by Seizure-related Movement Caused by Hyperglycemia and Epileptic Discharge with Dpoorly Controlled Diabetes Mmellitus Hyeongseok KIM Korea
P-3-28 A Case of Initial Neurologic Deterioration following Stevens-Johnson Syndrome in Patient with Wilson Disease Dong-Woo RYU Korea
P-3-29 Acute Hemichorea-hemiballism after Neurovascular Intervention Dayoung KIM Korea
P-3-30 A Case of Atypical Paroxysmal Kinesigenic Dyskinesia Confirmed by a Gene Test Byung Woo CHOI Korea
P-3-31 A Case of Dopa-responsive Dystonia That Mimic Cerebral Palsy Yongkyung LEE Korea
P-3-32 A Case of Brain Lymphoma Presenting Only with Palatal Myoclonus and Dizziness Sung Ho JO Korea
P-3-33 Delayed Initiation of Movement in a Patient with Cerebral Infarction Byoung Chul ChOI Korea
P-3-34 Two Cases of Pantothenate Kinase-associated Neurodegeneration Mimicking Essential Tremor with Literature Review Sungyang JO Korea
P-3-35 Klebsiella Pneumoniae Infection Presenting with Chorea Sue Hyun LEE Korea
P-3-36 Hemibody Multifocal Chorea Caused by Hypoperfusion in a Patient with Parkinsonism Gyihyaon YUN Korea
P-3-37 A Case of Spinocerebellar Ataxia Type2 Accompanied by Retrocollis and Parkinsonism Hyun Joon LEE Korea
P-3-38 Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine Jongmok HA Korea
P-3-39 Successful Pallidal Stimulation in a Patient with KMT2B-related Dystonia Jun Kyu MUN Korea
P-3-40 Restless Leg Syndrome in Chronic Hemodialysis Patient: Case Study Report Chuluunbaatar OTGONBAATAR Mongolia
P-3-41 A Young Male Suffering from Gradually Decreasing Intelligence, Spinal Myoclonus, Dysarthria and Psychotic Symptoms Changxu CUI China
P-3-42 Clinical and Electrophysiological Characteristics of a Type I Sialidosis Patient with a Novel Deletion Mutation in NEU1 Gene Sung-Pin FAN Taiwan
Diamond
  • 명인
Platinum
  • 룬드벡
  • 한독테바
  • 삼일
  • 한독
Gold+/Gold/Silver/Bronze
  • gsk
  • 베링거
  • 에자이
  • 메드트로닉
  • 현대
  • 환인
  • 종근당
MDS
Endorsed by the International Parkinson and Movement Disorder Society
Hosted ByThe Korean Movement Disorder Society
Hanhwa Obelisk Apt #2011, 33, Mapo-daero, Mapo-gu, Seoul, 04167, Korea
  • Tel. +82-2-6395-2876
  • Fax. +82-2-6395-2875
  • Email. parkinson@kmds.or.kr
  • Web. www.kmds.or.kr
  • Business Registration Number : 220-82-62625
  • Name of Representative : Yun Joong Kim
Secretariat of 2019 ICKMDS | LS Communications
6F Apgujeong B/D, 17, Cheonho-daero 85-gil, Dongdaemun-gu, Seoul 02644, Korea